7 transactions in 2 companies, from September 12, 2025 to October 15, 2025.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Keros Therapeutics, Inc. | KROS | 4 | — | $85.0M |
| LB PHARMACEUTICALS INC | LBRX | 3 | $15.0M | — |
7 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics, Inc. | KROS | Pontifax Management 4 G.P. (2015) Ltd.DirJOINT | Oct 15 | S | 155,262 | $17.75 | $2.8M | 0 |
| Keros Therapeutics, Inc. | KROS | Pontifax Management 4 G.P. (2015) Ltd.DirJOINT | Oct 15 | S | 1,226,412 | $17.75 | $21.8M | 0 |
| Keros Therapeutics, Inc. | KROS | Pontifax Management 4 G.P. (2015) Ltd.DirJOINT | Oct 15 | S | 1,121,045 | $17.75 | $19.9M | 0 |
| Keros Therapeutics, Inc. | KROS | Pontifax Management 4 G.P. (2015) Ltd.DirJOINT | Oct 15 | S | 2,284,612 | $17.75 | $40.6M | 0 |
| LB PHARMACEUTICALS INC | LBRX | Pontifax Management 4 G.P. (2015) Ltd.10%DERIV | Sep 12 | CConversion | 10,000,000 | — | — | 0derivatives |
| LB PHARMACEUTICALS INC | LBRX | Pontifax Management 4 G.P. (2015) Ltd.10% | Sep 12 | P | 1,000,000 | $15.00 | $15.0M | 1,411,681 |
| LB PHARMACEUTICALS INC | LBRX | Pontifax Management 4 G.P. (2015) Ltd.10% | Sep 12 | CConversion | 411,681 | — | — | 411,681 |